The role of complement activation in atherosclerosis (Q35838666)

10 August 2017

1 reference

title

The role of complement activation in atherosclerosis (English)

1 reference

10 August 2017

1 reference

Florin Niculescu

1

1 reference

10 August 2017

Horea Rus

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

30

1 reference

10 August 2017

1

1 reference

10 August 2017

73-80

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:30:1:073

10 August 2017

0 references

cites work

Complement C5b-9 increases plasminogen binding and activation on human endothelial cells

1 reference

12 December 2020

Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions

1 reference

12 December 2020

ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.

1 reference

12 December 2020

Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques

1 reference

12 December 2020

Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation

1 reference

12 December 2020

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

12 December 2020

Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall

1 reference

12 December 2020

C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas

1 reference

12 December 2020

Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis

1 reference

12 December 2020

Regulation of differentiation of vascular smooth muscle cells

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury

1 reference

12 December 2020

Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation

1 reference

12 December 2020

Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit

1 reference

12 December 2020

Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords

1 reference

12 December 2020

Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages

1 reference

12 December 2020

Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction

1 reference

12 December 2020

Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion

1 reference

12 December 2020

Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina.

1 reference

12 December 2020

Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions

1 reference

12 December 2020

Complement as a factor in arteriosclerosis

1 reference

12 December 2020

Break the cycle: the role of cell-cycle modulation in the prevention of vasculoproliferative diseases

1 reference

12 December 2020

Innate and acquired immunity in atherogenesis

1 reference

12 December 2020

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

1 reference

12 December 2020

Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors

1 reference

12 December 2020

RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase

1 reference

12 December 2020

Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits

1 reference

12 December 2020

Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position

1 reference

12 December 2020

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

12 December 2020

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

1 reference

12 December 2020

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

12 December 2020

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study

1 reference

12 December 2020

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety

1 reference

12 December 2020

Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation

1 reference

12 December 2020

Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers

1 reference

12 December 2020

CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions

1 reference

12 December 2020

Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

1 reference

12 December 2020

Complement activation by oxidatively modified low-density lipoproteins

1 reference

12 December 2020

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

1 reference

12 December 2020

Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation

1 reference

12 December 2020

Role of the C5b-9 complement complex in cell cycle and apoptosis

1 reference

12 December 2020

Chlamydia pneumoniae and atherosclerosis

1 reference

12 December 2020

Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha

1 reference

12 December 2020

Complement receptors and regulatory proteins in human atherosclerotic lesions

1 reference

12 December 2020

Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase

1 reference

12 December 2020

Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin.

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.

1 reference

12 December 2020

Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells

1 reference

12 December 2020

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

12 December 2020

Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall

1 reference

12 December 2020

The endothelium in atherogenesis

1 reference

12 December 2020

Influence of C3 deficiency on atherosclerosis

1 reference

12 December 2020

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

1 reference

12 December 2020

Quantitative determinations of immunoglobulins and complement components in human aortic atherosclerotic wall

1 reference

12 December 2020

Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque

1 reference

12 December 2020

Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1

1 reference

12 December 2020

Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis

1 reference

12 December 2020

Cells carrying C5b-9 complement complexes in human atherosclerotic wall

1 reference

12 December 2020

Complement activation and atherosclerosis

1 reference

12 December 2020

Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries

1 reference

12 December 2020

Complement activation and stimulation of chemotaxis by Chlamydia trachomatis

1 reference

12 December 2020

Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells

1 reference

12 December 2020

Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:30:1:073

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference